TFFP TFF Pharmaceuticals Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TFFP

Price (delayed)

$2.03

Market cap

$5.11M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$11.85

Enterprise value

-$248,842

TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform. Early testing confirms ...

Highlights
The EPS has soared by 55% year-on-year and by 9% since the previous quarter
The debt has contracted by 40% YoY and by 15% from the previous quarter
TFF Pharmaceuticals's gross profit has increased by 48% YoY but it has decreased by 21% from the previous quarter
The revenue is up by 48% year-on-year but it is down by 21% since the previous quarter
TFF Pharmaceuticals's quick ratio has shrunk by 85% YoY and by 73% QoQ
The equity has dropped by 58% year-on-year and by 30% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://tffpharma.com
Peers: OMER OMGA

Key stats

What are the main financial stats of TFFP
Market
Shares outstanding
2.52M
Market cap
$5.11M
Enterprise value
-$248,842
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.5
Price to sales (P/S)
4.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.34
Earnings
Revenue
$733,871
EBIT
-$21.24M
EBITDA
-$20.74M
Free cash flow
-$16.13M
Per share
EPS
-$11.85
Free cash flow per share
-$9
Book value per share
$4.04
Revenue per share
$0.41
TBVPS
$6.71
Balance sheet
Total assets
$12.03M
Total liabilities
$2.46M
Debt
$115,254
Equity
$9.57M
Working capital
$5.16M
Liquidity
Debt to equity
0.01
Current ratio
3.13
Quick ratio
2.26
Net debt/EBITDA
0.26
Margins
EBITDA margin
-2,826.2%
Gross margin
100%
Net margin
-2,894.7%
Operating margin
-2,983.4%
Efficiency
Return on assets
-144.8%
Return on equity
-163.1%
Return on invested capital
-476.7%
Return on capital employed
-221.3%
Return on sales
-2,894.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TFFP stock price

How has the TFF Pharmaceuticals stock price performed over time
Intraday
-20.08%
1 week
-30.48%
1 month
-59.4%
1 year
-86.78%
YTD
-71.08%
QTD
-66.39%

Financial performance

How have TFF Pharmaceuticals's revenue and profit performed over time
Revenue
$733,871
Gross profit
$733,871
Operating income
-$21.89M
Net income
-$21.24M
Gross margin
100%
Net margin
-2,894.7%
The net margin has soared by 55% YoY but it has contracted by 13% from the previous quarter
The operating margin has soared by 53% YoY but it has contracted by 16% from the previous quarter
TFF Pharmaceuticals's gross profit has increased by 48% YoY but it has decreased by 21% from the previous quarter
The revenue is up by 48% year-on-year but it is down by 21% since the previous quarter

Growth

What is TFF Pharmaceuticals's growth rate over time

Valuation

What is TFF Pharmaceuticals stock price valuation
P/E
N/A
P/B
0.5
P/S
4.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.34
The EPS has soared by 55% year-on-year and by 9% since the previous quarter
TFFP's price to book (P/B) is 88% lower than its 5-year quarterly average of 4.2 and 64% lower than its last 4 quarters average of 1.4
The equity has dropped by 58% year-on-year and by 30% since the previous quarter
The stock's price to sales (P/S) is 82% less than its last 4 quarters average of 27.1
The revenue is up by 48% year-on-year but it is down by 21% since the previous quarter

Efficiency

How efficient is TFF Pharmaceuticals business performance
The ROS has soared by 55% year-on-year but it is down by 13% since the previous quarter
The return on equity has declined by 24% year-on-year and by 12% since the previous quarter
The ROIC rose by 24% year-on-year
TFF Pharmaceuticals's return on assets has decreased by 21% YoY and by 7% QoQ

Dividends

What is TFFP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TFFP.

Financial health

How did TFF Pharmaceuticals financials performed over time
The total liabilities has soared by 106% from the previous quarter and by 98% YoY
TFF Pharmaceuticals's quick ratio has shrunk by 85% YoY and by 73% QoQ
The debt is 99% less than the equity
The equity has dropped by 58% year-on-year and by 30% since the previous quarter
The debt has contracted by 40% YoY and by 15% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.